412 top medical experts on Tumor Lysis Syndrome across 40 countries and 32 U.S. states, including 319 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lymphoproliferative Disorders (2,703).
  4. Clinical Trials ClinicalTrials.gov : at least 13 including 10 Completed, 1 Recruiting


  

        

                    


    Computing Expert Listing ...

);